PRFX Painreform Ltd
Company Analysis
Latest News
🔴 Painreform is trading 5.54% down today in pre-market with immediate catalyst unclear
Painreform is trading 5.54% down at $0.92 after declining from its September 2, 2026 close of $0.97; no clear immediate catalyst was identified. - No...
🟢 Painreform is trading 10.83% up in pre-market
Painreform is trading 10.83% up now at $1.08 after rising from the September 2 close of $0.97. - No clear company-specific announcement, earnings release, or...
🟢 Painreform is trading 6.18% up in pre-market with no clear company-specific catalyst
Painreform is trading 6.18% up in pre-market at $1.01, with no clear company-specific catalyst identified for September 2, 2026. - The latest identifiable...
🟢 Painreform is trading 7.09% up in pre-market — no confirmed company-specific catalyst identified
Painreform is trading 7.09% up at $1.03 after closing at $0.96 on August 28, 2026, with no confirmed company-specific catalyst identified. - No confirmed...
🟢 Painreform is trading 8.1% up in pre-market with no confirmed company-specific catalyst
Painreform is trading at $1.07, up +8.10%, with no confirmed company-specific announcement dated August 28, 2026 identified. - The latest listed company news...
🟢 Painreform is trading 6.93% up in pre-market amid broader market strength
Painreform is trading at $1.08 (+6.93%) in pre-market, with the gain appearing more consistent with broader market strength than a newly reported...
🟢 Painreform is trading 5.31% up in after-hours trading with no company-specific announcement explaining move
Painreform is trading 5.31% up at $1.05 in after-hours trading, with no reliable company-specific announcement dated August 21 directly explaining the move. -...
🟢 Painreform is trading 5% up today — no clear catalyst identified
Painreform is trading 5% up at $1.05, based on the provided live quote, with no reliable company-specific announcement dated August 21, 2026 identified to...
🟢 Painreform rises 6.2% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🔴 Painreform is trading 5.3% down today; no clear catalyst identified
Painreform is trading at $0.97 (-5.34%), with no clear company-specific catalyst identified. - Painreform declined 14.17% to $1.03 on August 14, 2026. - No...
🔴 Painreform is trading 5.8% down in pre-market
Painreform is trading 5.8% down at $0.97, with no clear company-specific catalyst identified. - Painreform fell 14.17% to $1.03 on August 14, 2026. - No...
🔴 Painreform is trading 11% down today with no clear catalyst identified
Painreform is trading at $1.07 (-10.83%) with no clear company-specific catalyst identified. - No company-specific announcement, filing, earnings release, or...
🔴 Painreform is trading 11.67% down in pre-market with no clear catalyst identified
Painreform is trading 11.67% down at $1.06 in pre-market, with no clear company-specific catalyst identified. - It closed at $1.20 on August 13, 2026. - No...
🔴 Painreform is trading 12% down in pre-market with no clear catalyst identified
Painreform is trading 11.67% down at $1.06 with no clear company-specific catalyst identified. - It closed at $1.20 on August 13, 2026. - No company-specific...
🔴 Painreform is trading 6.33% down in pre-market
Painreform is trading 6.33% down at $1.12 after closing at $1.20 on August 13, 2026, with no clear company-specific catalyst identified for August 14. - The...
🔴 Painreform is trading 9.17% down in after-hours trading with no clear catalyst identified
Painreform is trading 9.17% down at $1.09 in after-hours trading, with no clear company-specific catalyst identified after closing at $1.20 on August 13,...
🟢 Painreform is trading 5% up today — immediate driver remains unclear
Painreform is trading 5.08% up at $1.08 after opening-market strength on August 13, 2026, though the immediate driver remains unclear. - No reliable...
🟢 Painreform is trading 21.29% up in pre-market — no clear, reliable company-specific catalyst identified
Painreform is trading 21.29% up at $1.25, with no clear, reliable company-specific catalyst identified for the pre-market move. - It closed at $1.03 on August...
🟢 Painreform is trading 5.1% up in after-hours trading; catalyst unclear
Painreform is trading 5.05% up now at $1.08 after closing the regular session at $1.03, with no reliable company-specific catalyst identified for the...
🔴 Painreform is trading 5.45% down today with no confirmed catalyst
Painreform is trading 5.45% down at $1.04, with no confirmed company-specific catalyst identified. - Opened below the August 11, 2026 close of $1.10. -...